StemCell Institute (TSE:7096) Change In Payables And Accrued Expense : 円0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is StemCell Institute Change In Payables And Accrued Expense?

StemCell Institute's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was 円0 Mil. It means StemCell Institute's Accounts Payable & Accrued Expense stayed the same from Mar. 2024 to Sep. 2024 .

StemCell Institute's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2024 was 円0 Mil. It means StemCell Institute's Accounts Payable & Accrued Expense stayed the same from Mar. 2023 to Mar. 2024 .

StemCell Institute Change In Payables And Accrued Expense Historical Data

The historical data trend for StemCell Institute's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemCell Institute Change In Payables And Accrued Expense Chart

StemCell Institute Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

StemCell Institute Quarterly Data
	Mar18	Mar19	Dec19	Mar20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial													-	-	-	-	-

StemCell Institute Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

StemCell Institute Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of StemCell Institute's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

StemCell Institute Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemCell Institute (TSE:7096) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shimbashi, Minato-ku, Tamuracho Building, Matsuoka, Tokyo, JPN, 105-0004

Website

https://www.stemcell.co.jp

StemCell Institute is engaged in Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's own cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood.

StemCell Institute Headlines

No Headlines